SNMCY Financial Statements & Analysis
Complete financial statements for SNMCY including income statement, balance sheet, and cash flow statement. Analyze SNMCY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
15.7% ↑
Net Income
52.3% ↑
Gross Margin
-77.0% ↓
Operating Margin
59.0% ↑
Balance Sheet
Current Ratio
24.2% ↑
Debt to Equity
31.1% ↓
Asset Turnover
328.6% ↑
Cash Flow
Operating Cash Flow
2.1% ↑
Net Cash Flow
29.9% ↑
Free Cash Flow
2.1% ↑
Cash Flow to Debt
2.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 13.33B | 15.43B | 15.7% | |
| Gross Profit | 13.33B | 3.55B | 73.4% | |
| Operating Income | 1.50B | 2.77B | 84.0% | |
| Net Income | 1.20B | 1.82B | 52.3% | |
| EPS | 0.94 | 1.69 | 79.8% | |
| EBITDA | 1.95B | 2.93B | 50.1% | |
| Gross Margin | 100.00% | 23.02% | 77.0% | |
| Operating Margin | 11.29% | 17.94% | 59.0% | |
| Net Income Margin | 8.98% | 11.82% | 31.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 15.43B | 13.33B | 16.04B | — | — |
| Gross Profit | 3.55B | 13.33B | 16.04B | — | — |
| Operating Income | 2.77B | 1.50B | 3.41B | — | — |
| Net Income | 1.82B | 1.20B | 1.15B | — | — |
| EPS | 1.69 | 0.94 | 0.91 | — | — |
| EBITDA | 2.93B | 1.95B | 5.00B | — | — |
| Gross Margin | 23.02% | 100.00% | 100.00% | — | — |
| Operating Margin | 17.94% | 11.29% | 21.27% | — | — |
| Net Income Margin | 11.82% | 8.98% | 7.16% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into SNMCY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics